{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:05:25Z","timestamp":1785150325729,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.pbb.2020.172976","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T13:47:15Z","timestamp":1593179235000},"page":"172976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Agmatine reverses memory deficits induced by A\u03b21\u201342 peptide in mice: A key role of imidazoline receptors"],"prefix":"10.1016","volume":"196","author":[{"given":"Nandkishor","family":"Kotagale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Garmelwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Bhondekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.172976_bb0005","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1021\/acs.jmedchem.9b02080","article-title":"Bicyclic \u03b1-iminophosphonates as high affinity imidazoline I2 receptor ligands for Alzheimer\u2019s disease","volume":"63","author":"Abas","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2020.172976_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/nlme.2002.4076","article-title":"Agmatine facilitates memory of an inhibitory avoidance task in adult rats","volume":"78","author":"Arteni","year":"2002","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pbb.2020.172976_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.69.285","article-title":"Selective inhibition of inducible nitric oxide synthase by agmatine","volume":"69","author":"Auguet","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-3057(02)01079-1","article-title":"An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine","volume":"74","author":"Bence","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172976_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuroscience.2015.04.034","article-title":"A single intracerebroventricular A\u03b225\u201335 infusion leads to prolonged alterations in arginine metabolism in the rat hippocampus and prefrontal cortex","volume":"298","author":"Bergin","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172976_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","article-title":"Inflammation, microglia, and Alzheimer\u2019s disease","volume":"37","author":"Cameron","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2020.172976_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","article-title":"Peripheral clearance of brain-derived A\u03b2 in Alzheimer's disease: pathophysiology and therapeutic perspectives","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.pbb.2020.172976_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.02.045","article-title":"Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice","volume":"732","author":"Dixit","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/jnsbm.JNSBM_239_17","article-title":"Neuroprotective effect of agmatine in mouse spinal cord injury model: modulation by imidazoline receptors","volume":"9","author":"Dixit","year":"2018","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"10.1016\/j.pbb.2020.172976_bb0050","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.97.19.10584","article-title":"Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury","volume":"97","author":"Fairbanks","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.pbb.2020.172976_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-003-1392-3","article-title":"Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test","volume":"167","author":"Finn","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172976_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","article-title":"Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice","volume":"58","author":"Freitas","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0065","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2020.172976_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3160247","article-title":"Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine","volume":"316","author":"Galea","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbb.2020.172976_bb0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archpsyc.1996.01830090049008","article-title":"Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims","volume":"53","author":"Garcia-Sevilla","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172976_bb0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(98)00265-1","article-title":"Imidazoline receptor proteins in brains of patients with Alzheimer\u2019s disease","volume":"247","author":"Garc\u0131ia-Sevilla","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2020.172976_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13311-018-00681-5","article-title":"Behavioral and cognitive improvement induced by novel imidazoline I2 receptor ligands in female SAMP8 mice","volume":"16","author":"Grinan-Ferre","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2020.172976_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","article-title":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","volume":"353","author":"Guerra de Souza","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2020.172976_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pbb.2020.172976_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pbb.2020.172976_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2020.172976_bb0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11033-018-4501-4","article-title":"The neuroprotective effect of agmatine against amyloid \u03b2-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt\/GSK-3\u03b2, and TNF-\u03b1","volume":"46","author":"Hooshmandi","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.pbb.2020.172976_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/ijmm.2014.1801","article-title":"Bushen-Yizhi formula ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in scopolamine-induced senescence in mice","volume":"34","author":"Hou","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.pbb.2020.172976_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuropharm.2016.10.029","article-title":"Agmatine ameliorates type 2 diabetes induced-Alzheimer\u2019s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling","volume":"113","author":"Kang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172976_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0304-3940(02)01456-8","article-title":"Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats","volume":"339","author":"Karadag","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2020.172976_bb0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1526-4637.2010.00808.x","article-title":"Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Keynan","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.pbb.2020.172976_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2018.03.002","article-title":"Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: contribution of \u03b12-adrenoceptors","volume":"167","author":"Kotagale","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172976_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuro.2019.05.001","article-title":"Neuroprotective offerings by agmatine","volume":"73","author":"Kotagale","year":"2019","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.pbb.2020.172976_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainresbull.2020.04.013","article-title":"Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer's disease","volume":"160","author":"Kotagale","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2020.172976_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2020.06.002","article-title":"Involvement of hippocampal agmatine in \u03b21-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice","volume":"80","author":"Kotagale","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pbb.2020.172976_bb0160","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neuropharm.2014.01.011","article-title":"Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Ab1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice","volume":"79","author":"Lai","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172976_bb0165","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20170007","article-title":"Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?","volume":"474","author":"Laube","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbb.2020.172976_bb0170","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","article-title":"Agmatine: an endogenous clonidine-displacing substance in the brain","volume":"263","author":"Li","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pbb.2020.172976_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2011.07.054","article-title":"Pre-aggregated A\u03b225\u201335 alters arginine metabolism in the rat hippocampus and prefrontal cortex","volume":"193","author":"Liu","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172976_bb0180","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer\u2019s disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbb.2020.172976_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2015.11.040","article-title":"Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice","volume":"1631","author":"Liu","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0195","first-page":"33","article-title":"Influence of long-term moxonidine (psysiotens) monotherapy on neuropsychological status and brain perfusion in elderly patients with arterial hypertension","volume":"102","author":"Martynov","year":"2002","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.pbb.2020.172976_bb0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/hr.2010.6","article-title":"Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin resistant hypertensive patients-a randomized, crossover trial","volume":"33","author":"Masajtis-Zagajewska","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pbb.2020.172976_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","article-title":"Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony","volume":"239","author":"Medeiros","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2020.172976_bb0215","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1021\/jm301055g","article-title":"Identification of small molecule inhibitors of amyloid \u03b2-induced neuronal apoptosis acting through the imidazoline I2 receptor","volume":"55","author":"Montolio","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2020.172976_bb0220","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.neuropharm.2011.12.031","article-title":"Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation","volume":"62","author":"Moosavi","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172976_bb0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-2009-1051","article-title":"Brain-derived neurotrophic factor levels in Alzheimer\u2019s disease","volume":"17","author":"O\u2019Bryant","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbb.2020.172976_bb0230","first-page":"35","article-title":"Intrathecal melatonin increases the mechanical nociceptive threshold in the rat","volume":"16","author":"Onal","year":"2004","journal-title":"Agri"},{"key":"10.1016\/j.pbb.2020.172976_bb0235","first-page":"17","article-title":"Use of phisiotens for the treatment of arterial hypertension in elderly patients","volume":"73","author":"Ostroumova","year":"2001","journal-title":"TerArkh"},{"key":"10.1016\/j.pbb.2020.172976_bb0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2014.00170","article-title":"Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling","volume":"8","author":"Phillips","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pbb.2020.172976_bb0245","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2020.172976_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(96)00196-3","article-title":"Imidazoline binding sites in Huntington\u2019s and Parkinson\u2019s disease putmen","volume":"301","author":"Reynolds","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(93)90925-B","article-title":"Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease","volume":"160","author":"Ruiz","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2020.172976_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2012.02.021","article-title":"Aging affects l-arginine and its metabolites in memory-associated brain structures at the tissue and synaptoneurosome levels","volume":"209","author":"Rushaidhi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172976_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2013.01.004","article-title":"Effects of prolonged agmatine treatment in aged male Sprague\u2013Dawley rats","volume":"234","author":"Rushaidhi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172976_bb0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00001756-199601310-00032","article-title":"Decreased density of I2 imidazoline receptors in the post-mortem brains of heroin addicts","volume":"7","author":"Sastre","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2020.172976_bb0280","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2014.09.019","article-title":"Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer\u2019s disease mouse model","volume":"36","author":"Schmole","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbb.2020.172976_bb0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10253890802302908","article-title":"Modulation of stress by imidazoline binding sites: implications for psychiatric disorders","volume":"12","author":"Smith","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.pbb.2020.172976_bb0290","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2020.172976_bb0295","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3349\/ymj.2014.55.3.689","article-title":"Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model","volume":"55","author":"Song","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.pbb.2020.172976_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172743","article-title":"Diet and Alzheimer\u2019s dementia - nutritional approach to modulate inflammation","volume":"184","author":"Szczechowiak","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172976_bb0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involves modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172976_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","article-title":"Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats","volume":"637","author":"Taksande","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0315","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2013.12.002","article-title":"Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats","volume":"24","author":"Taksande","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172976_bb0320","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biopha.2016.12.039","article-title":"Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats","volume":"86","author":"Taksande","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.pbb.2020.172976_bb0325","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/acer.13972","article-title":"Agmatine inhibits behavioral sensitization to ethanol through imidazoline receptors","volume":"43","author":"Taksande","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0330","doi-asserted-by":"crossref","first-page":"172779","DOI":"10.1016\/j.pbb.2019.172779","article-title":"Agmatine reverses ethanol consumption in rats: evidences for an interaction with imidazoline receptors","volume":"186","author":"Taksande","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172976_bb0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JIN-170032","article-title":"2-(2-Benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis","volume":"16","author":"Tian","year":"2017","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.pbb.2020.172976_bb0340","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/syn.21541","article-title":"Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole), for the imidazoline binding site","volume":"66","author":"Tyacke","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2020.172976_bb0345","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.pbb.2012.07.003","article-title":"Agmatine, a metabolite of L-arginine, reverses scopolamine-induced learning and memory impairment in rats","volume":"102","author":"Utkan","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172976_bb0350","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2020.172976_bb0355","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy","volume":"34","author":"Xin","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pbb.2020.172976_bb0360","first-page":"1","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"1","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.pbb.2020.172976_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113818","article-title":"Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease","author":"Zuccarello","year":"2020","journal-title":"Biochem. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720303403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720303403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:37:37Z","timestamp":1758775057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305720303403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":73,"alternative-id":["S0091305720303403"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172976","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine reverses memory deficits induced by A\u03b21\u201342 peptide in mice: A key role of imidazoline receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172976"}}